Osteoimmunity-Regulating Biomimetically Hierarchical Scaffold for Augmented Bone Regeneration
Jin Zhang1, Dongmei Tong2, Honghai Song3,4
1College of Chemical Engineering, Qingyuan Innovation Laboratory, Fuzhou University, 2 Xueyuan Road, Fuzhou, 350108, P. R. China.
Advanced Materials (Deerfield Beach, Fla.)
|July 5, 2022
Summary
This study developed a novel biomaterial scaffold that balances the immune system and bone metabolism, significantly enhancing bone regeneration. The scaffold promotes vascularization and bone formation while reducing inflammation for improved bone repair.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Immunomodulation
- Bone Regeneration
Background:
- Effective bone tissue regeneration requires precise control over the immune response post-biomaterial implantation.
- Existing strategies often struggle to balance pro-regenerative and anti-inflammatory signals.
- A hierarchical scaffold integrating immunomodulatory and osteogenic cues is needed for enhanced bone repair.
Purpose of the Study:
- To fabricate a biomimetically hierarchical scaffold for augmenting bone repair by balancing immune response and bone metabolism.
- To investigate the scaffold's ability to modulate macrophage phenotype, promote angiogenesis, and enhance osteogenesis.
- To evaluate the in vitro and in vivo efficacy of the osteoimmunity-regulating scaffold for large-scale bone defect repair.
Main Methods:
- Fabrication of a 3D printed scaffold combining deferoxamine@poly(ε-caprolactone) nanoparticles (DFO@PCL NPs), manganese carbonyl (MnCO) nanosheets, gelatin methacryloyl hydrogel, and a polylactide/hydroxyapatite (HA) matrix.
- Utilized a Fenton-like reaction for controlled release of carbon monoxide and Mn2+ from MnCO nanosheets.
- Assessed immunomodulatory effects by analyzing macrophage polarization (M2 phenotype) and vascular endothelial growth factor (VEGF) secretion.
- Investigated the role of Mn2+ and DFO@PCL NPs in activating the hypoxia-inducible factor-1α (HIF-1α) pathway to promote angiogenesis.
- Evaluated osteoclast differentiation inhibition by DFO and osteogenic activity synergy with HA.
- Performed in vitro and in vivo experiments to assess overall bone regeneration efficacy.
Main Results:
- The scaffold successfully mimicked bone tissue structure and extracellular matrix properties.
- MnCO nanosheets triggered a Fenton-like reaction, releasing CO and Mn2+ to reduce inflammation by upregulating M2 macrophages.
- Upregulated M2 macrophages secreted VEGF, promoting vascular formation.
- Mn2+ and DFO@PCL NPs activated the HIF-1α pathway, enhancing angiogenesis.
- DFO inhibited osteoclast differentiation, while HA exhibited osteoinductive activity, showing synergistic effects.
- The scaffold demonstrated strong immunomodulatory, angiogenic, and osteogenic properties with weak osteoclastogenic potential.
Conclusions:
- The developed osteoimmunity-regulating scaffold significantly improves bone regeneration by harmonizing immune responses and bone metabolism.
- This biomaterial presents a promising strategy for addressing large-scale bone defects through its multi-faceted regenerative capabilities.
- The findings provide a valuable foundation and positive outlook for future advancements in bone defect repair.


